08
October 2024
Past Event
Do Drug Patents Cause High Drug Prices?

Event will air on this page.

 

Inquiries: [email protected]

Do Drug Patents Cause High Drug Prices?

Past Event
Online Only
October 08, 2024
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
Caption
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
08
October 2024
Past Event

Event will air on this page.

 

Inquiries: [email protected]

Speakers:
Adam Mossoff
Adam Mossoff

Chair, Forum for Intellectual Property and Senior Fellow

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law
Erika Lietzan

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Vice President and Global Head of Intellectual Property Affairs, Novartis
Corey A. Salsberg

Vice President and Global Head of Intellectual Property Affairs, Novartis

Moderator:
hartline
Devlin Hartline

Senior Fellow

For the past decade, policy activists have argued that drug innovators artificially extend the length of their exclusive patent protections on their drugs solely to keep drug prices high. One activist organization, the Initiative for Medicines, Access, and Knowledge (I-MAK), alleges that as many as 50 patents currently protect drugs from generic competition. 

But are I-MAK’s patent numbers correct? A 2022 Hudson policy memo, “How Unreliable Data Has Infected the Policy Debate Over Drug Patents,”detailed how I-MAK’s patent numbers contradict the number of drug patents listed in the Orange Book, the Food and Drug Administration’s official database of drug patents. Academic scholars have also done rigorous empirical studies, and the United States Patent and Trademark Office (USPTO) released its own empirical study in June 2024. Neither the USPTO nor the academic studies could replicate or confirm activist organizations’ patent numbers. Yet I-MAK’s claims continue to drive legislative proposals and agency actions.

Join Hudson for an expert discussion on the state of play concerning the empirical evidence on the connection between drug patents and drug prices and whether officials are engaging in evidence-based policymaking on this pressing concern.

Related Events
28
July 2025
Virtual Event | Online Only
Strategic Realignments: The Middle East After the Israel-Iran Conflict
Featured Speakers:
Dan Diker
David Wurmser
Michael Doran
Moderator:
Zineb Riboua
Getty Images
28
July 2025
Virtual Event | Online Only
Strategic Realignments: The Middle East After the Israel-Iran Conflict

Experts will examine how Israel’s decision to act independently has impacted its relationship with the United States, what the war’s outcome signals for Iran’s regional ambitions, and how key players like Turkey, Saudi Arabia, and Syria are recalibrating in its aftermath.

Getty Images
Featured Speakers:
Dan Diker
David Wurmser
Michael Doran
Moderator:
Zineb Riboua
28
July 2025
In-Person Event | Hudson Institute
Postponed | Bridging the Valley of Death: Using Experimentation to Solve Operational Problems
Featured Speakers:
Joy Shanaberger
Dan Ermer
Capt. Raymond G. Stromberger
Gary Western
David Schmolke
Yi Chao
Rick Berger
Gina Pizziconi
Alex Lovett
Dan Edwards
Moderators:
Dan Lamothe
Bryan Clark
Dan Patt
DVIDS
28
July 2025
In-Person Event | Hudson Institute
Postponed | Bridging the Valley of Death: Using Experimentation to Solve Operational Problems

Please join Hudson Institute Senior Fellow Bryan Clark, US defense officials, and industry leaders for an event highlighting the DoD’s recent accomplishments in translating concept to capability through experimentation in support of the nation’s most urgent military challenges.

DVIDS
Featured Speakers:
Joy Shanaberger
Dan Ermer
Capt. Raymond G. Stromberger
Gary Western
David Schmolke
Yi Chao
Rick Berger
Gina Pizziconi
Alex Lovett
Dan Edwards
Moderators:
Dan Lamothe
Bryan Clark
Dan Patt
25
July 2025
Past Event
After the 12-Day War: Reassessing Military Power in the Middle East
Featured Speakers:
Michael Doran
Bryan Clark
Can Kasapoğlu
Getty Images
25
July 2025
Past Event
After the 12-Day War: Reassessing Military Power in the Middle East

Senior Fellows Michael Doran, Bryan Clark, and Can Kasapoğlu will explore the implications of this shift for the United States, Israel, and their partners and discuss how Iran might respond.

Getty Images
Featured Speakers:
Michael Doran
Bryan Clark
Can Kasapoğlu
25
July 2025
Past Event
Gazan Humanitarian Foundation Chairman Johnnie Moore on How Food Distribution Could Determine Hamas’s Fate
Featured Speakers:
Johnnie Moore
Nina Shea
Getty Images
25
July 2025
Past Event
Gazan Humanitarian Foundation Chairman Johnnie Moore on How Food Distribution Could Determine Hamas’s Fate

Reverend Moore will also discuss how the GHF can help distribute UN food aid that is currently sequestered in trucks inside the Gaza strip—a request that the secretary general and his deputy at the UN Office for the Coordination of Humanitarian Affairs (OCHA) have thus far ignored.

Getty Images
Featured Speakers:
Johnnie Moore
Nina Shea